Molecular modelling of CYP2A enzymes: application to metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)

Reference

• AIDA, K., MOORE, R. and NEGISHI, M., 1994, Lack of the steroid 15a-hydroxylase gene (CYP2A-4) in wild mouse strain Mus spretus: rapid evolution of the P450 gene superfamily. Genomics, 19, 564–566.
   PubMed Web of Science ®Google Scholar
• BATHELT, C., SCHMID, R. D. and PLEISS, J., 2002, Regioselectivity of CYP2B6: homology modeling, molecular dynamics simulation, docking. Journal of Molecular Modelling (Online), 8, 327–335.
   PubMedGoogle Scholar
• BERENDSEN, H. J. C., POSTMA, J. P. M., GUNSTEREN, W. F., DiNoLA, A. and HAAK, J. R., 1984, Molecular dynamics with coupling to an external bath. Journal of Chemistry and Physics, 81, 3684–3690.
   Google Scholar
• CASE, D. A., PEARLMAN, D. A., CALDWELL, J. W., CHEATHAM, T. E., WANG, J., Ross, W. S., SIMMERLING, C. L., DARDEN, T. A., MERZ, K. M., STANTON, R. V., CHENG, A. L., VINCENT, J. J., CROWLEY, M., TSUI, V., RADMER, R. J., GOHLKE, H., DUAN, Y., PITERA, J., MASSOVA, I., SEIBEL, G. L., SINGH, U. C., WEINER, P. K. and KOLLMAN, P. A., 2002, AMBER 7, University of San Francisco.
   Google Scholar
• CHENNA, R., SUGAWARA, H., KOIKE, T., LOPEZ, R., GIBSON, T. J., HIGGINS, D. G. and THOMPSON, J. D., 2003, Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Research, 31, 3497–3500.
   PubMed Web of Science ®Google Scholar
• DE GROOT, M. J., ALEX, A. A. and JONES, B. C., 2002, Development of a combined protein and pharmacophore model for cytochrome P450 2C9. Journal of Medical Chemistry, 45, 1983–1993.
   PubMedGoogle Scholar
• DING, X. and KAMINSKY, L. S., 2003, Human extrahepatic cytochromes P450: Function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annual Reviews in Pharmacology and Toxicology, 43, 149–173.
   PubMed Web of Science ®Google Scholar
• ESSMANN, U., PERERA, L., BERKOWITZ, M. L., DARDEN, T. and PEDERSEN, L. G., 1995, A smooth particle mesh Ewald method. Journal of Chemistry and Physics, 103, 8577–8593.
   Web of Science ®Google Scholar
• FELICIA, N. D., REKHA, G. K. and MURPHY, S. E., 2000, Characterization of cytochrome P450 2A4 and 2A5-catalysed 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone (NNK) metabolism. Archives in Biochemistry and Biophysics, 384, 418–424.
   PubMedGoogle Scholar
• GOROKHOV, A., NEGISHI, M., JOHNSON, E. F., PEDERSEN, L. C., PERERA, L., DARDEN, T. A. and PEDERSEN, L. G., 2003, Explicit water near the catalytic I helix Thr in the predicted solution structure of CYP2A4. Biophysics Journal, 84, 57–68.
   PubMedGoogle Scholar
• GOTOH, 0., 1992, Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences 3016. Journal of Biological Chemistry, 267, 83–90.
   Google Scholar
• Guo, Z., SMITH, T. J., IsHizmu, H. and YANG, C. S., 1991, Metabolism of 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone (NNK) by cytochrome P45011B1 in a reconstituted system. Carcinogenesis (London), 12, 2277–2282.
   PubMed Web of Science ®Google Scholar
• HARRIS, D. and LOEW, G., 1995, Prediction of regiospecific hydroxylation of camphor analogs by cytochrome P450cam. Journal of the American Chemistry Society, 117, 2738–2746.
   Web of Science ®Google Scholar
• HE, X., SHEN, J., SUN, L., DING, X., Lu, A. and HONG, J.-Y., 2003, American Association for Cancer Research National Meeting, Washington, DC, 11–15 July 2003.
   Google Scholar
• HECHT, S. S., 1998, Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chemical Research in Toxicology, 11, 559–603.
   PubMed Web of Science ®Google Scholar
• HECHT, S. S., 1999, Tobacco smoke carcinogens and lung cancer. Journal of the National Cancer Institute, 91, 1194–1210.
   PubMed Web of Science ®Google Scholar
• HECHT, S. S., 2002, Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncology, 3, 461–469.
   PubMed Web of Science ®Google Scholar
• HECHT, S. S., 2003, Tobacco carcinogens, their biomarkers, and tobacco-induced cancer. Nature Reviews Cancer, 3, 733–744.
   PubMed Web of Science ®Google Scholar
• HONG, J. Y., DING, X., SMITH, T. J., COON, M. J. and YANG, C. S., 1992, Metabolism of 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone (NNK), a tobacco-specific carcinogen, by rabbit nasal microsomes and cytochrome P450s NMa and NMb. Carcinogenesis (London), 13, 2141–2144.
   PubMed Web of Science ®Google Scholar
• IWASAKI, M., DARDEN, T. A., PARKER, C. E., TOMER, K. B., PEDERSEN, L. G. and NEGISHI, M., 1994, Inherent versatility of P-450 oxygenase. Conferring dehydroepiandrosterone hydroxylase activity to P-450 2a-4 by a single amino acid mutation at position 117. Journal of Biological Chemistry, 269, 9079–9083.
   PubMed Web of Science ®Google Scholar
• IWASAKI, M., DARDEN, T. A., PEDERSEN, L. G. and NEGISHI, M., 1995a, Altering the regiospecificity of androstenedione hydroxylase activity in P450s 2A-4/5 by a mutation of the residue at position 481. Biochemistry, 34, 5054–5059.
   PubMed Web of Science ®Google Scholar
• IWASAKI, M., DARDEN, T. A., PEDERSEN, L. G., DAVIS, D. G., JUVONEN, R. 0., SUEYOSHI, T. and NEGISHI, M., 1993a, Engineering mouse P450coh to a novel corticosterone 15alpha-hydroxylase and modeling steroid-binding orientation in the substrate pocket. Journal of Biological Chemistry, 268, 759–762.
   Google Scholar
• IWASAKI, M., DAVIS, D. G., DARDEN, T. A., PEDERSEN, L. G. and NEGISHI, M., 1995b, Multiple steroid-binding orientations: alteration of regiospecificity of dehydroepiandrosterone 2- and 7-hydroxylase activities of cytochrome P-450 2A-5 by mutation of residue 209. Biochemistry Journal, 306, 29–33.
   PubMed Web of Science ®Google Scholar
• IWASAKI, M., LINDBERG, R. L. P., JUVONEN, R. 0. and NEGISHI, M., 1993b, Site-directed mutagenesis of mouse steroid 7 cc-hydroxylase (cytochrome P-45070): role of residue-209 in determining steroid-cytochrome P-450 interaction. Biochemistry Journal, 291, 569–573.
   Google Scholar
• JALAS, J. R., DING, X. and MURPHY, S. E., 2003a, Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone (NNK) and 4-(methylnitrosa-mino)-1-(3-pyridy1)-1-butanol (NNAL) by rat cytochrome P450 2A3 and human cytochrome P450 2A13. Drug Metabolism and Disposition, 31, 1199–1202.
   PubMed Web of Science ®Google Scholar
• JALAS, J. R., MCINTEE, E. J., KENNEY, P. M., UPADHYAYA, P., PETERSON, L. A. and HECHT, S. S., 2003b, Stereospecific deuterium substitution attenuates the tumorigenicity and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone (NNK). Chemical Research in Toxicology, 16, 794–806.
   PubMedGoogle Scholar
• JUVONEN, R. 0., IWASAKI, M. and NEGISHI, M., 1991, Structural function of residue-209 in coumarin 7-hydroxylase (P450coh). Enzyme-kinetic studies and site-directed mutagenesis. Journal of Biological Chemistry, 266, 16431–16435.
   Google Scholar
• JUVONEN, R. 0., IwAsmu, M., SUEYOSHI, T. and NEGISHI, M., 1993, Structural alteration of mouse P450coh by mutation of glycine-207 to proline: spin equilibrium, enzyme kinetics, and heat sensitivity. Biochemistry Journal, 294, 31–34.
   Google Scholar
• KUMAR, S., SCOTT, E. E., Liu, H. and HALPERT, J. R., 2003, A rational approach to re-engineer cytochrome P450 2B1 regioselectivity based on the crystal structure of cytochrome P450 2C5. Journal of Biological Chemistry, 278, 17178–17184.
   PubMed Web of Science ®Google Scholar
• LEWIS, D. F. V., 1999, Homology modeling of human cytochromes P450 involved in xenobiotic metabolism and rationalization of substrate selectivity. Experimental Toxicology and Pathology, 51, 369–374.
   PubMed Web of Science ®Google Scholar
• LEWIS, D. F. V., 2002a, Homology modelling of human CYP2 family enzymes based on the CYP2C5 crystal structure. Xenobiotica, 32, 305–323.
   PubMedGoogle Scholar
• LEWIS, D. F. V., 2002b, Modelling human cytochromes P450 involved in drug metabolism from the CYP2C5 crystallographic template. Journal of Inorganic Biochemistry, 91, 502–514.
   PubMed Web of Science ®Google Scholar
• LEWIS, D. F. V., DICKINS, M., LAKE, B. G., EDDERSHAW, P. J., TARBIT, M. H. and GOLDFARB, P. S., 1999, Molecular modelling of the human cytochrome P450 isoform CYP2A6 and investigations of CYP2A substrate selectivity. Toxicology, 133, 1–33.
   Google Scholar
• LINDBERG, R. L. P. and NEGISHI, M., 1989, Alteration of Mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue. Nature, 339, 632–634.
   Google Scholar
• Liu, J., ERICKSEN, S. S., BESSPIATA, D., FISHER, C. W. and SZKLARZ, G. D., 2003, Characterization of substrate binding to cytochrome P450 1A1 using molecular modeling and kinetic analyses: case of residue 382. Drug Metabolism and Disposition, 31, 412–420.
   PubMed Web of Science ®Google Scholar
• MODI, S., SUTCLIFFE, M. J., PRIMROSE, W. U., LIAN, L. Y. and ROBERTS, G. C., 1996, The catalytic mechanism of cytochrome P450 BM3 involves a 6 A movement of the bound substrate on reduction. Nature Structure in Biology, 3, 414–417.
   PubMedGoogle Scholar
• MORRIS, G. M., GOODSELL, D. S., HALLIDAY, R. S., HUEY, R., HART, W. E., BELEW, R. K. and OLSON, A. J., 1998, Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computers in Chemistry, 19, 1639–1662.
   Web of Science ®Google Scholar
• NEGISHI, M., IWASAKI, M., JUVENON, R. 0. and AIDA, K., 1992, Alteration of the substrate specificity of mouse 2A P450s by the identity of residue-209: steroid-binding site and orientation. Journal of Steroids in Biochemistry and Molecular Biology, 43, 1031–1036.
   Google Scholar
• NEGISHI, M., UNO, T., HONKAKOSKI, P., SUEYOSHI, T., DARDEN, T. A. and PEDERSEN, L. P., 1996, The roles of individual amino acids in altering substrate specificity of the P450 2A4/2A5 enzymes. Biochimie, 78, 685–694.
   PubMed Web of Science ®Google Scholar
• ORTIZ DE MONTELLANO, P. R. (1995) Oxygen activation and reactivity. In P. R. Ortiz de Montellano (ed.), Cytochrome P450: Structure, Mechanism, and Biochemistry, (New York: Plenum), pp. 245–303.
   Google Scholar
• PARK, J. Y. and HARRIS, D., 2003, Construction and assessment of models of CYP2E1: predictions of metabolism from docking, molecular dynamics, and density functional theoretical calculations. Journal of Medical Chemistry, 46, 1645–1660.
   PubMed Web of Science ®Google Scholar
• PATTEN, C. J., SMITH, T. J., MURPHY, S. E., WANG, M. H., LEE, J., TYNES, R. E., KOCH, P. and YANG, C. S., 1996, Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes. Archives in Biochemistry and Biophysics, 333, 127–138.
   PubMed Web of Science ®Google Scholar
• PAULY, G. T., PETERSON, L. A. and MOSCHEL, R. C., 2002, Mutagenesis by 06-[4-oxo-4-(3-pyridyl)butyl]guanine in Escherichia coli and human cells. Chemical Research in Toxicology, 15, 165–169.
   PubMedGoogle Scholar
• PELKONEN, P., LANG, M. A., NEGISHI, M., WILD, C. P. and JuvoNEN, R. 0., 1997, Interaction of afiatoxin B1 with cytochrome P450 2A5 and its mutants: correlation with metabolic activation and toxicity. Chemical Research in Toxicology, 10, 85–90.
   Google Scholar
• PERLMAN, D. A., CASE, D. A., CALDWELL, J. W., Ross, W. S., CHEATHAM, T. E., DEBOLT, S., FERGUSON, D. M., SEIBEL, G. and KOLLMAN, P. A., 1995, AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics, and free energy calculations to simulate the structural and energetic properties of molecules. Computers in Physics Communications, 91, 1–41.
   Google Scholar
• PETERSON, L. A., MATHEW, R. and HECHT, S. S., 1991, Quantitation of microsomal alpha-hydroxylation of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone. Cancer Research, 51, 5495–5500.
   PubMed Web of Science ®Google Scholar
• PODUST, L. M., KIM, Y., ARASE, M., NEELY, B. A., BECK, B. J., BACH, H., SHERMAN, D. H., LAMB, D. C., KELLY, S. L. and WATERMAN, M. R., 2003, The 1.92-A structure of Streptomyces coelicolor A3(2) CYP154C1. A new monooxygenase that functionalizes macrolide ring systems. Journal of Biological Chemistry, 278, 12214–12221.
   PubMed Web of Science ®Google Scholar
• PODUST, L. M., PouLos, T. L. and WATERMAN, M. R., 2001, Crystal structure of cytochrome P450 14alpha-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proceedings of the National Academy of Sciences, USA, 98, 3068–3073.
   PubMed Web of Science ®Google Scholar
• PouLos, T. L., CUPP-VICKERY, J. and LI, H. (1995) Structural studies on prokaryotic cytochromes P450. In P. R. Ortiz de Montellano (ed.), Cytochrome P450: Structure, Mechanism, and Biochemistry (New York: Plenum), pp. 125–150.
   Google Scholar
• RYCKAERT, J. P., CICCOTTI, G. and BERENDSEN, H. J. C., 1977, Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. Journal of Computers in Physics, 23, 327–342.
   Web of Science ®Google Scholar
• SCHALK, M. and CROTEAU, R., 2000, A single amino acid substitution (F363I) converts the regiochemistry of the spearmint (—)-limonene hydroxylase from a C6- to a C3-hydroxylase. Proceedings of the National Academy of Sciences, USA, 97, 11948–11953.
   PubMed Web of Science ®Google Scholar
• SCOTT, E. E., HE, Y. A., WESTER, M. R., WHITE, M. A., CHIN, C. C., HALPERT, J. R., JOHNSON, E. F. and STOUT, C. D., 2003, An open conformation of mammalian cytochrome P450 2B4 at 1.6-A resolution. Proceedings of the National Academy of Sciences, USA, 100, 13196–13201.
   PubMed Web of Science ®Google Scholar
• SMITH, T. J., Guo, Z., GUENGERICH, F. P. and YANG, C. S., 1996, Metabolism of 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate. Carcinogenesis, 17, 809–813.
   PubMed Web of Science ®Google Scholar
• Su, T., BAO, Z., ZHANG, Q. Y., SMITH, T. J., HONG, J. Y. and DING, X., 2000, Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone. Cancer Research, 60, 5074–5079.
   PubMed Web of Science ®Google Scholar
• UPADHYAYA, P., STURLA, S. J., TRETYAKOVA, N., ZIEGEL, R., VILLALTA, P. W., WANG, M. and HECHT, S. S., 2003, Identification of adducts produced by the reaction of 4-(acetoxymethylnitrosamino)-1-(3-pyridy1)-1-butanol with deoxyguanosine and DNA. Chemical Research in Toxicology, 16, 180–190.
   PubMedGoogle Scholar
• VENHORST, J., TER LAAK, A. M., COMMANDEUR, J. N. M., FUNAE, Y., HIROI, T. and VERMEULEN, N. P. E., 2003, Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities. Journal of Medical Chemistry, 46, 74–86.
   Google Scholar
• VON WEYMARN, L. and MURPHY, S. E., 2003, Cytochrome P450CYP 2A13-catalysed coumarin metabolism, comparison to CYPP450 2A5 and CYP2A6. Xenobiotica, 33, 73–81.
   PubMedGoogle Scholar
• VON WEYMARN, L. B. and MURPHY, S. E., 2001, Coumarin metabolism by rat esophageal microsomes and cytochrome P450 2A3. Chemical Research in Toxicology, 14, 1386–1392.
   PubMed Web of Science ®Google Scholar
• WANG, J., CIEPLAK, P. and KOLLMAN, P. A., 2000, How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? Journal of Computers in Chemistry, 21, 1049–1074.
   Google Scholar
• WANG, M., CHENG, G., STURLA, S. J., SHI, Y., MCINTEE, E. J., VILLALTA, P. W., UPADHYAYA, P. and HECHT, S. S., 2003, Identification of adducts formed by pyridyloxobutylation of deoxyguanosine and DNA by 4-(acetoxymethylnitrosamino)-1-(3-pyridy1)-1-butanone, a chemically activated form of tobacco-specific carcinogens. Chemical Research in Toxicology, 16, 616–626.
   PubMedGoogle Scholar
• WESTER, M. R., JOHNSON, E. F., MARQUES-SOARES, C., DANSETTE, P. M., MANSUY, D. and STOUT, C. D., 2003a, Structure of a substrate complex of mammalian cytochrome P450 2C5 at 2.3 A resolution: evidence for multiple substrate binding modes. Biochemistry, 42, 6370–6379.
   Google Scholar
• WESTER, M. R., JOHNSON, E. F., MARQUES-SOARES, C., DIJOLS, S., DANSETTE, P. M., MANSUY, D. and STOUT, C. D., 2003b, Structure of mammalian cytochrome P450 2C5 complexed with diclofenac at 2.1. Ang. resolution: evidence for an induced fit model of substrate binding. Biochemistry, 42, 9335–9345.
   Google Scholar
• WILLIAMS, P. A., COSME, J., SRIDHAR, V., JOHNSON, E. F. and MuREE, D. E., 2000, Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. Molecular Cell, 5, 121–131.
   PubMed Web of Science ®Google Scholar
• WILLIAMS, P. A., COSME, J., WARD, A., ANGOVE, H. C., MATAK, V. D. and Noll, H., 2003, Crystal structure of human cytochrome P450 2C9 with bound warfarin. Nature, 424, 464–468.
   PubMed Web of Science ®Google Scholar
• XU, C., RAO, Y. S., Xu, B., HOFFMANN, E., JONES, J., SELLERS, E. M. and TYNDALE, R. F., 2002, An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 alleles. Biochemical and Biophysical Research Communications, 290, 318–324.
   PubMed Web of Science ®Google Scholar
• ZHANG, X., SU, T., ZHANG, Q. Y., Gu, J., CAGGANA, M., LI, H. and DING, X., 2002, Genetic polymorphisms of the human CYP2A13 gene: identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant. Journal of Pharmacology and Experimental Therapeutics, 302, 416–423.
   PubMed Web of Science ®Google Scholar